Atlas Trials

Apatinib in Refractory Colorectal Cancer

Clinical trial NCT03190616 · COMPLETED

Trial details

NCT number
NCT03190616
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Neoplasms
Start date
2017-07-01
Primary completion
2019-06-30
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.